Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alpha Teknova (TKNO) Capital Expenditures: 2020-2025

Historic Capital Expenditures for Alpha Teknova (TKNO) over the last 5 years, with Sep 2025 value amounting to $387,000.

  • Alpha Teknova's Capital Expenditures rose 16.92% to $387,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 57.13%. This contributed to the annual value of $1.1 million for FY2024, which is 85.82% down from last year.
  • As of Q3 2025, Alpha Teknova's Capital Expenditures stood at $387,000, which was up 86.96% from $207,000 recorded in Q2 2025.
  • In the past 5 years, Alpha Teknova's Capital Expenditures ranged from a high of $10.9 million in Q2 2022 and a low of $112,000 during Q1 2024.
  • Its 3-year average for Capital Expenditures is $896,273, with a median of $331,000 in 2024.
  • In the last 5 years, Alpha Teknova's Capital Expenditures spiked by 284.55% in 2021 and then crashed by 97.40% in 2024.
  • Quarterly analysis of 5 years shows Alpha Teknova's Capital Expenditures stood at $7.4 million in 2021, then plummeted by 36.18% to $4.7 million in 2022, then crashed by 93.40% to $312,000 in 2023, then soared by 81.73% to $567,000 in 2024, then climbed by 16.92% to $387,000 in 2025.
  • Its Capital Expenditures was $387,000 in Q3 2025, compared to $207,000 in Q2 2025 and $206,000 in Q1 2025.